Building Economic Resilience to the Health Impacts of Climate Change 2025
Page 31 of 49 · WEF_Building_Economic_Resilience_to_the_Health_Impacts_of_Climate_Change_2025.pdf
5.4 Interventions
Healthcare providers and businesses can act to protect their
workforce and the communities they serve while capturing new
economic opportunities.
Health and healthcare interventions TABLE 8
As dengue escalates due to climate change,
Takeda’s vaccine offers a critical preventive tool.
Now, through active participation in the Collective
Action on Dengue (CAD) initiative, Takeda is
helping scale climate-resilient healthcare by
aligning innovation with cross-sector coordination.
The coalition, launched at the 2023 United
Nations Climate Change Conference (COP28)
and supported by over 30 stakeholders, cultivates
collaboration across urban health, innovation and financing. Takeda contributes technical
and strategic expertise, accelerating access to
vaccines and strengthening health systems in
climate-vulnerable regions. By working through the
coalition, Takeda helps integrate vaccination into
broader prevention strategies – ensuring equitable
delivery, informing policy and advancing joint
planning. Overall, this partnership drives scalable,
sustainable dengue prevention in an era of rising
climate risk.Takeda and the Collective Action on Dengue initiative BOX 81 Develop novel drugs, products
and services
Pharmaceutical and medical device companies
can adapt their R&D pipelines to address shifting
disease patterns, emerging pathogens and
conditions driven by climate change. In this effort,
improved forecasting will be critical to unlocking
investment and scaling innovation.Developing novel drugs, medical devices and
diagnostics for climate-related illnesses is
increasingly commercially attractive, with patient
populations and demand growing across new
markets. Similarly, care facilities can develop more
effective patient treatment pathways (including
community-based preventative care schemes),
more efficiently treating those suffering from
climate-related illnesses.Healthcare value chain
Pharmaceuticals
and life sciencesSystem-level care planning
and administrationPatient care
and treatment
Interventions
for consumers1 Develop novel drugs, products
and services, focusing on diseases
intensified by climate change.3 Establish care centres
in climate-vulnerable regions
(including telehealth and mobile
care options equipped to address
climate-health risks).
2 Improve climate resilience
of existing portfolios of drugs,
products and services,
e.g. thermal stability of drugs. 4 Retrofit estates and care facilities to increase capacity for demand
surges and ensure infrastructure is climate-resilient.
5 Scale up provision of preventative healthcare to mitigate the effects
of climate-related illness.
Interventions
for the workforce6 Implement cooling solutions
in healthcare facilities, as well
as heat stress monitoring and
management.
7 Protect workers with clothing/equipment and specialized training to raise awareness of growing climate health
risks and reduce risk exposure.
8 Implement comprehensive
mental health support for
practitioners, including proactive
strategies and treatment.
Building Economic Resilience to the Health Impacts of Climate Change 31
Ask AI what this page says about a topic: